Trials / Completed
CompletedNCT03159195
Ibrance Real World Insights
TREATMENT PATTERNS AND CLINICAL OUTCOMES AMONG PATIENTS RECEIVING PALBOCICLIB COMBINATIONS FOR HR+/HER2- ADVANCED/METASTATIC BREAST CANCER IN REAL WORLD SETTINGS
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 652 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To describe patient demographics, clinical characteristics, treatment patterns and clinical outcomes of adult female patients who have received palbociclib combination treatments in line with regional licensed indications in real world settings across multiple countries.
Conditions
Timeline
- Start date
- 2017-06-12
- Primary completion
- 2020-07-23
- Completion
- 2021-06-24
- First posted
- 2017-05-18
- Last updated
- 2025-07-01
- Results posted
- 2021-09-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03159195. Inclusion in this directory is not an endorsement.